Literature DB >> 2060522

Some aspects of the epidemiology of toxoplasmosis and pneumocystosis in AIDS in Europe.

N Clumeck1.   

Abstract

The incidence and prevalence of Toxoplasma gondii and Pneumocystis carinii infections among AIDS patients in Europe are different from those observed in the USA. These differences are probably causally related to differences in host exposure, and sociocultural and nutritional habits.

Entities:  

Mesh：

Year:  1991        PMID： 2060522     DOI： 10.1007/bf01964454

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  3 in total

1.  Toxoplasmosis: the time has come.

Authors:  R McCabe; J S Remington
Journal:  N Engl J Med       Date:  1988-02-04       Impact factor: 91.245

2.  Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends.

Authors:  R M Selik; E T Starcher; J W Curran
Journal:  AIDS       Date:  1987-09       Impact factor: 4.177

3.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.

Authors:  B A Navia; C K Petito; J W Gold; E S Cho; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422
  3 in total
  7 in total

Review 1.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  Arboprotozoae.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

3.  Toxoplasmic encephalitis in AIDS-patients before and after the introduction of highly active antiretroviral therapy (HAART).

Authors:  T R Kiderlen; O Liesenfeld; D Schürmann; T Schneider
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-15       Impact factor: 3.267

4.  Effects of 2',3'-dideoxyinosine on Toxoplasma gondii cysts in mice.

Authors:  M E Sarciron; P Lawton; C Saccharin; A F Petavy; F Peyron
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  Penetration of clindamycin and its metabolite N-demethylclindamycin into cerebrospinal fluid following intravenous infusion of clindamycin phosphate in patients with AIDS.

Authors:  G Gatti; M Malena; R Casazza; M Borin; M Bassetti; M Cruciani
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

6.  Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition.

Authors:  J P Chave; A Munafo; J Y Chatton; P Dayer; M P Glauser; J Biollaz
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

7.  Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease.

Authors:  U Kastenbauer; E Wolf; C Kollan; O Hamouda; J R Bogner
Journal:  Eur J Med Res       Date:  2009-06-18       Impact factor: 2.175
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.